CAM
EIDX
Cormorant Asset Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-993,185
| Closed | -$50.2M | – | 112 |
|
|
2020
Q3 | $50.2M | Sell |
993,185
-62,117
| -6% | -$3.14M | 1.93% | 16 |
|
|
2020
Q2 | $50.3M | Sell |
1,055,302
-44,698
| -4% | -$2.13M | 1.92% | 16 |
|
|
2020
Q1 | $53.9M | Buy |
1,100,000
+604,308
| +122% | +$29.6M | 2.5% | 12 |
|
|
2019
Q4 | $28.4M | Sell |
495,692
-44,994
| -8% | -$2.58M | 1.14% | 28 |
|
|
2019
Q3 | $19.4M | Sell |
540,686
-11,235
| -2% | -$404K | 1.18% | 25 |
|
|
2019
Q2 | $17.2M | Buy |
551,921
+44,357
| +9% | +$1.38M | 0.99% | 29 |
|
|
2019
Q1 | $11.9M | Buy |
507,564
+121,718
| +32% | +$2.85M | 0.8% | 37 |
|
|
2018
Q4 | $5.31M | Hold |
385,846
| – | – | 0.43% | 41 |
|
|
2018
Q3 | $3.85M | Hold |
385,846
| – | – | 0.25% | 48 |
|
|
2018
Q2 | $7.46M | Buy |
+385,846
| New | +$7.46M | 0.55% | 41 |
|